Standards for utilization review performance modified, cause of action created for wrongful denials of prior authorizations by utilization review organizations, attorney general enforcement provided, fines by commissioner of commerce authorized, and oversight required.
HF3867 would significantly revise Minnesota’s utilization review laws, which govern how health plans and utilization review organizations decide whether to approve or deny medical services before they are provided. The bill tightens procedural requirements for prior authorization decisions, including requiring more direct communication with treating providers, clearer and timely notice of adverse determinations, and disclosure of the reasons and criteria used to deny coverage. It also limits retrospective changes to an already approved prior authorization, allowing revocation or restriction only in cases of fraud, misinformation, or conflict with state or federal law.
The bill creates a new private cause of action for enrollees harmed by a wrongful denial of prior authorization, if the denial and appeal both depart from accepted medical practice, conflict with the treating professional’s recommendation, and cause injury. Successful plaintiffs could recover damages, including punitive damages, injunctive relief, and attorney fees. The bill also authorizes enforcement by the attorney general, allows the commissioner of commerce to impose fines when reversal rates on appeals exceed 40 percent over a 12-month period, and directs health-related licensing boards to enforce professional standards in utilization review by their licensees.
HF3867 would amend Minnesota Statutes chapter 62M and add new provisions in chapters 62M and 214, expanding state oversight of utilization review organizations and prior authorization practices. It would affect health plans, utilization review organizations, claims administrators, providers, enrollees, the commissioner of commerce, the attorney general, and health-related licensing boards. The bill would also create new legal exposure for utilization review organizations through civil litigation and administrative enforcement, while preserving immunity for attending health care professionals.
No committee transcript or vote record was provided, so the bill’s sentiment must be inferred from its content and caption. The measure appears to be consumer- and provider-protective, aimed at reducing inappropriate prior authorization denials and improving accountability in health coverage decisions. Its structure suggests support for patients and treating clinicians, while imposing stronger compliance obligations on insurers and utilization review entities.
The likely points of contention are the new private right of action, the availability of punitive damages and attorney fees, and the commissioner’s authority to fine organizations based on appeal reversal rates. Utilization review organizations and health plan companies would likely object to increased liability, regulatory oversight, and potential pressure to approve more services. Supporters would likely emphasize patient harm from wrongful denials, the need for transparency, and deference to treating professionals. The bill also raises questions about how the 40 percent reversal threshold would be applied and whether it could penalize organizations for legitimate denials that are later overturned.